These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 10483843)

  • 41. [Substitution of dexamethasone for dexamphetamine due to their written and spoken similarity].
    Hoppenbrouwers CJ; Mooren GC; van den Heuvel JJ; Op de Coul ME; van Trotsenburg PA
    Ned Tijdschr Geneeskd; 2010; 154():A1662. PubMed ID: 20858310
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Sustained release methylphenidate for the treatment of ADHD in amphetamine abusers: a pilot study.
    Konstenius M; Jayaram-Lindström N; Beck O; Franck J
    Drug Alcohol Depend; 2010 Apr; 108(1-2):130-3. PubMed ID: 20015599
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A randomized, double-blind and placebo-controlled trial of modafinil in children and adolescents with attention deficit and hyperactivity disorder.
    Kahbazi M; Ghoreishi A; Rahiminejad F; Mohammadi MR; Kamalipour A; Akhondzadeh S
    Psychiatry Res; 2009 Aug; 168(3):234-7. PubMed ID: 19439364
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Twenty-four-week treatment with extended release methylphenidate improves emotional symptoms in adult ADHD.
    Rösler M; Retz W; Fischer R; Ose C; Alm B; Deckert J; Philipsen A; Herpertz S; Ammer R
    World J Biol Psychiatry; 2010 Aug; 11(5):709-18. PubMed ID: 20353312
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Short-term side effects of stimulant medication are increased in preschool children with attention-deficit/hyperactivity disorder: a double-blind placebo-controlled study.
    Firestone P; Musten LM; Pisterman S; Mercer J; Bennett S
    J Child Adolesc Psychopharmacol; 1998; 8(1):13-25. PubMed ID: 9639076
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cessation of attention deficit hyperactivity disorder drugs in the young (CADDY)--a pharmacoepidemiological and qualitative study.
    Wong IC; Asherson P; Bilbow A; Clifford S; Coghill D; DeSoysa R; Hollis C; McCarthy S; Murray M; Planner C; Potts L; Sayal K; Taylor E
    Health Technol Assess; 2009 Oct; 13(50):iii-iv, ix-xi, 1-120. PubMed ID: 19883527
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Double-blind, placebo-controlled study of zinc sulfate in the treatment of attention deficit hyperactivity disorder.
    Bilici M; Yildirim F; Kandil S; Bekaroğlu M; Yildirmiş S; Değer O; Ulgen M; Yildiran A; Aksu H
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jan; 28(1):181-90. PubMed ID: 14687872
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Efficacy of a mixed amphetamine salts compound in adults with attention-deficit/hyperactivity disorder.
    Spencer T; Biederman J; Wilens T; Faraone S; Prince J; Gerard K; Doyle R; Parekh A; Kagan J; Bearman SK
    Arch Gen Psychiatry; 2001 Aug; 58(8):775-82. PubMed ID: 11483144
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Assessment and management of attention-deficit hyperactivity disorder in adults.
    Weiss M; Murray C
    CMAJ; 2003 Mar; 168(6):715-22. PubMed ID: 12642429
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical effects beyond cocaine use of sustained-release dexamphetamine for the treatment of cocaine dependent patients with comorbid opioid dependence: secondary analysis of a double-blind, placebo-controlled randomized trial.
    Blanken P; Nuijten M; van den Brink W; Hendriks VM
    Addiction; 2020 May; 115(5):917-923. PubMed ID: 31908066
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of stimulants on 24-h ambulatory blood pressure in children with ADHD: a double-blind, randomized, cross-over trial.
    Samuels JA; Franco K; Wan F; Sorof JM
    Pediatr Nephrol; 2006 Jan; 21(1):92-5. PubMed ID: 16254730
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Using n-of-1 trials as a clinical tool to improve prescribing.
    Nikles CJ; Clavarino AM; Del Mar CB
    Br J Gen Pract; 2005 Mar; 55(512):175-80. PubMed ID: 15808031
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pilot randomized double blind placebo-controlled study of dexamphetamine for cocaine dependence.
    Shearer J; Wodak A; van Beek I; Mattick RP; Lewis J
    Addiction; 2003 Aug; 98(8):1137-41. PubMed ID: 12873248
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pharmacotherapy of adolescent attention deficit hyperactivity disorder: challenges, choices and caveats.
    Garland EJ
    J Psychopharmacol; 1998; 12(4):385-95. PubMed ID: 10065914
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparing guanfacine and dextroamphetamine for the treatment of adult attention-deficit/hyperactivity disorder.
    Taylor FB; Russo J
    J Clin Psychopharmacol; 2001 Apr; 21(2):223-8. PubMed ID: 11270920
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cannabinoids in attention-deficit/hyperactivity disorder: A randomised-controlled trial.
    Cooper RE; Williams E; Seegobin S; Tye C; Kuntsi J; Asherson P
    Eur Neuropsychopharmacol; 2017 Aug; 27(8):795-808. PubMed ID: 28576350
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Lisdexamfetamine in the treatment of attention-deficit/hyperactivity disorder in adults.
    Rostain AL
    Curr Psychiatry Rep; 2009 Oct; 11(5):341-2. PubMed ID: 19785973
    [No Abstract]   [Full Text] [Related]  

  • 58. Long-term stimulant treatment of children with attention-deficit hyperactivity disorder symptoms. A randomized, double-blind, placebo-controlled trial.
    Gillberg C; Melander H; von Knorring AL; Janols LO; Thernlund G; Hägglöf B; Eidevall-Wallin L; Gustafsson P; Kopp S
    Arch Gen Psychiatry; 1997 Sep; 54(9):857-64. PubMed ID: 9294377
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Six-year outcome in subjects diagnosed with attention-deficit/hyperactivity disorder as adults.
    Edvinsson D; Ekselius L
    Eur Arch Psychiatry Clin Neurosci; 2018 Jun; 268(4):337-347. PubMed ID: 29143159
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Efficacy, safety and variability in pharmacotherapy for adults with attention deficit hyperactivity disorder: a meta-analysis and meta-regression in over 9000 patients.
    Cunill R; Castells X; Tobias A; Capellà D
    Psychopharmacology (Berl); 2016 Jan; 233(2):187-97. PubMed ID: 26446868
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.